Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New video laryngoscope may help novice doctors intubate faster

NCT ID NCT07174050

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a new video laryngoscope (King Vision) helps less experienced doctors place a breathing tube faster than the traditional method. Seventy adult patients having elective surgery took part. The goal was to see if the device reduces time and improves success on the first try.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
King Vision Channeled Video Laryngoscope
What this could lead to
If successful, this could show that the King Vision videolaryngoscope helps novice doctors place breathing tubes faster and more easily than the traditional method.
What could go wrong
This is a small, completed study with only 70 participants, so results may not apply to all patients or settings. The device may not improve outcomes for experienced users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Jan 2023

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years old) scheduled for elective surgery under general anesthesia requiring orotracheal intubation * American Society of Anesthesiologists (ASA) physical status I-II * Mallampati airway classification I-II * Written informed consent obtained from the patient Exclusion Criteria: * Predicted or known difficult airway: Mallampati III-IV, inter-incisor distance \<2.5 cm, thyromental distance \<6 cm, limited cervical spine mobility * History of difficult intubation or need for awake/rapid-sequence intubation * Upper airway pathology (tumour, trauma, infection), limited mouth opening, or craniofacial anomalies * Emergency surgery, high aspiration risk, or full stomach * Severe cardiopulmonary instability (e.g., shock, severe hypoxaemia) * Pregnancy or breastfeeding * BMI \>35 kg/m² (if your protocol excludes obesity; remove if not applicable) * Participation refusal or inability to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Airway management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Izmir City Hospital

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.